Claims for Patent: 10,293,073

Summary for Patent: 10,293,073

Title:	Moisture management for wound care
Abstract:	There is provided an absorbent system for wound care products having a liquid-absorbing, wound-contacting, lower layer and a more highly absorbent upper layer in liquid communication with said lower layer. Liquid communication may be provided by pores running between the layers. The dressing may include antimicrobial agents, agents to promote healing and other functional agents.
Inventor(s):	Gann; John P. (Portland, OR), Soerens; Dave A. (Neenah, WI)
Assignee:	Avent, Inc. (Alpharetta, GA)
Application Number:	15/506,054
Patent Claims:	1. A wound dressing for covering a wound of a patient, comprising: a wound-contacting lower layer having a first liquid absorption rate and a first degree of crosslinking, the lower layer comprising one or more lower perforations configured therethrough; and an upper layer configured adjacent to the lower layer, the upper layer comprising one or more upper perforations configured therethrough and aligning with the one or more lower perforations, the upper layer being in liquid communication with the lower layer via the aligned one or more upper perforations and the one or more lower perforations, the upper layer having a second liquid absorption rate, the upper layer comprising a superabsorbent polymer having a second degree of crosslinking, the second liquid absorption rate being higher than the first liquid absorption rate, the second degree of crosslinking of the upper layer being lower than the first degree of crosslinking of the lower layer. 2. The wound dressing of claim 1, wherein the one or more lower and upper perforations comprise at least one of pores, channels, or slits. 3. The wound dressing of claim 1, wherein the superabsorbent polymer of the upper layer is dispersed in a hydrogel. 4. The wound dressing of claim 1, wherein the upper layer comprises an absorbent foam, the foam comprising a liquid absorption rate that is higher than the first liquid absorption rate the lower layer. 5. The wound dressing of claim 1, wherein liquid communication is provided by physical contact between the layers. 6. The wound dressing of claim 1, wherein at least one of the lower layer or the upper layer further comprises one or more additives. 7. The wound dressing of claim 6, wherein the one or more additives comprise at least one of silver salts, silver nanoparticles, silver sulfadiazine, bacitracin, neomycin, polymyxin b, sulfacetamide sodium, sulfur, quaternary ammonium compounds, or povidone iodine. 8. The wound dressing of claim 1, wherein at least one of the lower layer or the upper layer further comprises agents to promote wound healing, the agents comprising at least one of oxygen, nitrogen oxide, growth factors, vitamin C, vitamin E, aloe, or combinations thereof. 9. The wound dressing of claim 1, wherein at least one of the lower layer or the upper layer further comprises one or more debriding agents, the one or more debriding agents comprises at least one of papain, honey, trypsin, collagenase, urea, or combinations thereof. 10. A wound dressing for covering a wound of a patient, comprising: a wound-contacting lower layer having a first liquid absorption rate and a first degree of crosslinking, the lower layer comprising one or more lower perforations configured therethrough; and an upper layer configured adjacent to the lower layer and facing away from the patient, the upper layer comprising one or more upper perforations configured therethrough and aligning with the one or more lower perforations, the upper layer being in liquid communication with the lower layer via the aligned one or more lower perforations configured in the lower layer and the one or more upper perforations configured in the upper layer, the upper layer having a second liquid absorption rate, the upper layer comprising a superabsorbent polymer having a second degree of crosslinking, the second liquid absorption rate being higher than the first liquid absorption rate, the second degree of crosslinking of the upper layer being lower than the first degree of crosslinking of the lower layer. 11. The wound dressing of claim 10, wherein the lower layer comprises a superabsorbent polymer having a predetermined degree of crosslinking. 12. The wound dressing of claim 11, wherein the one or more lower and upper perforations comprise at least one of pores, channels, or slits. 13. The wound dressing of claim 10, wherein the upper layer comprises an absorbent foam, the foam comprising a liquid absorption rate that is higher than the first liquid absorption rate the lower layer. 14. The wound dressing of claim 10, wherein liquid communication is further provided by physical contact between the layers. 15. The wound dressing of claim 10, wherein at least one of the lower layer or the upper layer further comprises one or more additives, wherein the one or more additives comprise at least one of silver salts, silver nanoparticles, silver sulfadiazine, bacitracin, neomycin, polymyxin b, sulfacetamide sodium, sulfur, quaternary ammonium compounds, or povidone iodine.

Details for Patent 10,293,073

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2034-08-29